ECOR 13.49 (+5.97%)
US28531P1030Medical Devices & InstrumentsMedical Instruments & Supplies

ElectroCore (ECOR) Stock Highlights

13.49 | +5.97%
2024-11-09 06:02:01
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The companys product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients. The gammaCore is CE-marked in the European Union for the acute and/or prophylactic treatment of primary headache, Bronchoconstriction and Medication Overuse Headache in adults.

Statistics

Range Today
12.7 13.68
Volume Today 112.9K
Range 1 Year
5.02 13.25
Volume 1 Year 5.31M
Range 3 Year
2.92 14.77
Volume 3 Year 24.31M
Range 10 Year
2.92 303.75
Volume 10 Year 99.63M

Highlights

Market Capitalization 86.97M (small)
Floating Shares 4.45M
Current Price 13.49
Price To Earnings -6.2
Price To Revenue 3.6
Price To Book 7.58
Earnings Per Share -2.05
Payout Ratio 0%

Performance

Latest +5.97%
1 Month +69.69%
3 Months +113.11%
6 Months +94.66%
1 Year +137.5%
3 Years -7.73%
5 Years -41.6%
10 Years -95%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.